Market Research Logo

Global Head and Neck Cancer Treatment Market 2017-2021

Global Head and Neck Cancer Treatment Market 2017-2021

About Head & Neck Cancer Treatment

Head and neck cancer usually starts in the squamous cells that lines the moist, mucosal surface present inside the head and neck. This type of cancer is further categorized by the affected areas such as oral cavity cancer, laryngeal cancer, pharyngeal cancer and other head and neck cancer. Other head and neck cancer includes salivary gland cancer, nasal cavity, and paranasal sinuses cancer.

Technavio’s analysts forecast the global head & neck cancer treatment market to grow at a CAGR of 8.07% during the period 2017-2021.

Covered in this report

The report covers the present scenario and the growth prospects of the global head & neck cancer treatment market for 2017-2021. To calculate the market size, the report considers sales of both branded and generic drugs in the global head and neck cancer treatment market.

The market is divided into the following segments based on geography:

  • Americas
  • APAC
  • EMEA
Technavio's report, Global Head & neck cancer treatment market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors
  • Bristol-Myers Squibb
  • Eli Lilly
  • Merck
  • Pfizer
Other prominent vendors
  • Amgen
  • Dr. Reddy's Laboratories
  • GlaxoSmithKline
  • Mylan
  • Sun Pharmaceutical Industries
  • Takeda Pharmaceuticals
  • Teva Pharmaceuticals
Market driver
  • Rising incidence of head and neck cancer
  • For a full, detailed list, view our report
Market challenge
  • Severe side effects of drugs
  • For a full, detailed list, view our report
Market trend
  • Outpatient care for head and neck cancer patients
  • For a full, detailed list, view our report
Key questions answered in this report
  • What will the market size be in 2021 and what will the growth rate be?
  • What are the key market trends?
  • What is driving this market?
  • What are the challenges to market growth?
  • Who are the key vendors in this market space?
  • What are the market opportunities and threats faced by the key vendors?
  • What are the strengths and weaknesses of the key vendors?


Press Release

Technavio Announces the Publication of its Research Report – Global Head & neck cancer treatment market 2017-2021

Technavio recognizes the following companies as the key players in the global head & neck cancer treatment market: Bristol-Myers Squibb, Eli Lilly, Merck, and Pfizer.

Other Prominent Vendors in the market are: Amgen, Dr. Reddy's Laboratories, GlaxoSmithKline, Mylan, Sun Pharmaceutical Industries, Takeda Pharmaceuticals, and Teva Pharmaceuticals.

Commenting on the report, an analyst from Technavio’s team said: “One trend in the market is outpatient care for head and neck cancer patients. Outpatient care for the cancer patients have been found to be equally effective compared with the inpatient care. In the outpatient treatment, the cancer patient can receive the treatment at their desired place, home being one of them.”

According to the report, one driver in the market is rising incidence of head and neck cancer. Rising incidence of the head and neck cancer is the major factor leading to the higher demand of the drugs and treatment. Apart from alcohol and tobacco consumption, HPV infection is turning out to be one of the major causative agents responsible for rising incidence of the disease. Approximately 70-90% of new oropharyngeal cancers have evidence of HPV.

Further, the report states that one challenge in the market is severe side effects of drugs. There are large number of side effects associated with the treatment of head and neck cancer. This has been a major challenge for the market. The aim of the treatment is to get rid of the cancerous cells. However, these treatments can have different effects on different people, as each set of drugs used for the treatment have its own type of side effect.



Companies Mentioned

Bristol-Myers Squibb, Eli Lilly, Merck, Pfizer, Amgen, Dr. Reddy's Laboratories, GlaxoSmithKline, Mylan, Sun Pharmaceutical Industries, Takeda Pharmaceuticals, and Teva Pharmaceuticals.

  • Executive summary
  • Scope of the report
  • Research Methodology
  • Introduction
    • Market outline
    • Head and neck cancer disease overview
      • Table Major areas affected by head and neck cancer
      • Table Symptoms and diagnosis of head and cancer
      • Table Treatment options for head and neck cancer
  • Market introduction
    • Market overview
      • Table Global head and neck market snapshot
    • Market size and forecast
      • Table Global head and neck cancer treatment market 2016-2021 ($ millions)
      • Table Opportunity analysis in global head and neck cancer treatment market
    • Five forces analysis
      • Table Five forces analysis
  • Pipe line landscape
    • Table Pipeline analysis
  • Market segmentation by cancer type
    • Table Global head and neck cancer treatment market by cancer type 2016
    • Table Market share of global head and neck cancer treatment market by cancer type
    • Oral cavity cancer
      • Table Global oral cavity cancer treatment market 2016-2021 ($ millions)
      • Table Median survival rate of oral cavity cancer
    • Laryngeal Cancer
      • Table Stages of laryngeal cancer
      • Table Global laryngeal cancer treatment market 2016-2021 ($ millions)
    • Pharyngeal Cancer
      • Table Types of pharyngeal cancer
      • Table Global pharyngeal cancer treatment market 2016-2021 ($ millions)
    • Other head and neck cancer
      • Table Global other segment for head and neck cancer treatment market 2016-2021 ($ millions)
  • Geographical segmentation
    • Table Global head and neck cancer treatment market by geography 2016 and 2021
    • Table Head and neck cancer treatment market revenue by geography 2016-2021 ($ millions)
    • Head and neck cancer treatment market in Americas
      • Table Market scenario in Americas
      • Table Head and neck treatment market in Americas 2016-2021 ($ millions)
    • Head and neck cancer treatment market in EMEA
      • Table Market scenario in EMEA
      • Table Head and neck treatment market in EMEA 2016-2021 ($ millions)
    • Head and neck cancer treatment market in APAC
      • Table Head and neck treatment market in APAC 2016-2021 ($ millions)
  • Decision framework
  • Drivers and challenges
    • Market drivers
      • Table Percentage distribution of population aging 60 years and above 2015-2050
    • Market challenges
  • Market trends
    • Combination therapy
    • Outpatient care for head and neck cancer patients
    • Increasing consolidation in cancer treatment market
  • Vendor landscape
    • Competitive scenario
      • Table Competitive structure analysis of head and neck cancer treatment market 2016
      • Table Strategic success factors of companies in global stem cell therapy market
  • Key vendor analysis
    • Bristol-Myers Squibb
      • Table Key highlights
      • Table BMS: Strength assessment
      • Table BMS: Strategy assessment
      • Table BMS: Opportunity assessment
    • Eli Lilly
      • Table Eli Lilly: Key highlights
      • Table Eli Lilly: Strength assessment
      • Table Eli Lilly: Strategy assessment
      • Table Eli Lilly: Opportunity assessment
    • Merck
      • Table Merck: Key highlights
      • Table Merck: Strength assessment
      • Table Merck Strategy assessment
      • Table Merck: Opportunity assessment
    • Pfizer
      • Table Pfizer: Key highlights
      • Table Pfizer: Strength assessment
      • Table Pfizer: Strategy assessment
      • Table Pfizer: Opportunity assessment
    • Other prominent vendor
  • Appendix
    • List of abbreviations
  • Explore Technavio

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report